Matthew Del Bel

机构：Pfizer (United States), Worldwide Clinical Trials (United States)

发表论文 18 篇 · 总被引 1072 次 · h-index 7

代表论文

• Hindered dialkyl ether synthesis with electrogenerated carbocations (2019 · Nature · 被引 399)
• Practical C−H Functionalization of Quinones with Boronic Acids (2011 · Journal of the American Chemical Society · 被引 370)
• 1,2-Difunctionalized bicyclo[1.1.1]pentanes: Long–sought-after mimetics for ortho / meta -substituted arenes (2021 · Proceedings of the National Academy of Sciences · 被引 123)
• Enantioselective Chemical Syntheses of the Furanosteroids (−)-Viridin and (−)-Viridiol (2017 · Journal of the American Chemical Society · 被引 69)
• Design and Synthesis of Functionally Active 5-Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1 (2023 · Journal of Medicinal Chemistry · 被引 41)
• Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of Cancer (2024 · Journal of Medicinal Chemistry · 被引 23)